3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
6
Carcinoma, Renal Cell
5
Brain Neoplasms
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Kidney Neoplasms
2
Glioma
2
Glioblastoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Astrocytoma
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Thyroid cancer, medullary
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Pain
1
Osteosarcoma
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Interventions
Morphine
7
Fentanyl
5
Radiotherapy
4
Methadone
4
Zoledronic Acid
3
Tapentadol
2
Ropivacaine
2
Pregabalin
2
Prednisone
2
Ketamine
2
Ibandronic Acid
2
Hydromorphone
2
Glutamine
2
Cryotherapy
2
Cryosurgery
2
Bupivacaine
2
Acupuncture Therapy
2
Acetaminophen
2
pegfilgrastim
1
oxycodone naloxone combination
1
naloxegol
1
ixabepilone
1
incobotulinumtoxinA
1
imisopasem manganese
1
cyclobenzaprine
1
cabozantinib
1
acetaminophen, aspirin, caffeine drug combination
1
Zolpidem
1
Surveys and Questionnaires
1
Sugars
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Pain
×
cabozantinib
×
Clear all
NCT01522443
2018-05-23
COMET-2
Exelixis
Phase 3
Terminated
119 enrolled
21 charts